Researcher's Work from Zhejiang University Focuses on Hormones (Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions).

A recent study conducted by researchers at Zhejiang University in Hangzhou, China, focused on the use of serum anti-Mullerian hormone (AMH) levels to indicate premenopausal endometrial lesions. The study included a total of 1209 patients with polycystic ovary syndrome (PCOS) and 5366 women without PCOS. The researchers found that for PCOS patients aged 20-39 years, a serum AMH level of 5.39 ng/mL was the most effective screening threshold, while for non-PCOS women in the same age group, a serum AMH value of 2.18 ng/mL was determined to be the optimal screening threshold. The study concluded that the serum AMH test and related multiple regression models could be used to warn of endometrial proliferative lesions in both PCOS and non-PCOS women aged 20-39 years. [Extracted from the article]